Literature DB >> 30561747

Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.

Liwen Wang1,2, Panpan Zhang1, Xia Zhang1, Wei Lin3, Hanqi Tang1,2, Jieqiong Li1, Mu Wang4, Xiaowei Liu5, Yunyun Fei1, Hua Chen1, Linyi Peng1, Li Zhang1, Yamin Lai6, Xuejun Zeng7, Xuemei Li8, Huadan Xue9, Yan Zhao1, Fengchun Zhang1, Wen Zhang1.   

Abstract

OBJECTIVES: To study the impact of sex on the clinical presentation of IgG4-related disease (IgG4-RD).
METHODS: We prospectively enrolled 403 newly diagnosed IgG4-RD patients. We compared the demographic features, clinical manifestations, organ involvement, laboratory tests and treatment outcomes between female and male patients. The organs involved were divided into superficial organs (salivary glands, lacrimal glands, orbit, sinus and skin) and internal organs (all the other organs). The patients treated with glucocorticoids with or without additional immunosuppressants were included in the assessment of treatment outcomes, and potential confounding factors were corrected by propensity score matching or multivariate Cox regression analysis.
RESULTS: Female patients showed younger age at both symptom onset and diagnosis, and a longer interval between symptom onset and diagnosis. Allergy history, Mikulicz's disease and thyroiditis were more common in female patients, while autoimmune pancreatitis, sclerosing cholangitis and retroperitoneal fibrosis were more common in male patients. In accordance, female patients more frequently presented with superficial organ involvement, while male patients more frequently had internal organ involvement, and the discrepancy was more prominent in the patients with older age. Male sex was associated with higher peripheral eosinophils, CRP and IgG4 levels at baseline. In response to glucocorticoid-based therapies, male sex was associated with a higher IgG4-RD responder index during follow-up as well as a greater risk of relapse (hazard ratio 3.14, P = 0.003).
CONCLUSION: Our study revealed the sex disparities in clinical characteristics of IgG4-RD, and indicated that male sex was independently associated with worse prognosis in response to glucocorticoid-based therapies.
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IgG4-related disease; clinical characteristics; glucocorticoids; prognosis; sex

Year:  2019        PMID: 30561747     DOI: 10.1093/rheumatology/key397

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Shin Hamada; Ichiro Tsuji; Yoshifumi Takeyama; Tooru Shimosegawa; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2019-12-23       Impact factor: 7.527

Review 2.  [Immunoglobulin-G4-related disease].

Authors:  Jasper F Nies; Martin Krusche
Journal:  Z Rheumatol       Date:  2022-06-29       Impact factor: 1.530

3.  Clinical features and treatment efficacy for IgG4-related thyroiditis.

Authors:  Xinxin Han; Panpan Zhang; Jieqiong Li; Zheng Liu; Hui Lu; Xuan Luo; Boju Pan; Xiaolan Lian; Xuejun Zeng; Wen Zhang; Xiaofeng Zeng
Journal:  Orphanet J Rare Dis       Date:  2021-07-21       Impact factor: 4.123

4.  Immunoglobulin G4-related lacrimal sac dacryocystocele: A novel case report.

Authors:  Sunny Chi Lik Au; Kai Ching Peter Leung; Edwin Chan; Simon Tak Chuen Ko
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-20

5.  Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China.

Authors:  Yu Chen; Yuanji Dong; Shaozhe Cai; Cong Ye; Lingli Dong
Journal:  Semin Arthritis Rheum       Date:  2020-05-16       Impact factor: 5.532

6.  Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score.

Authors:  Jieqiong Li; Yu Peng; Yuelun Zhang; Panpan Zhang; Zheng Liu; Hui Lu; Linyi Peng; Liang Zhu; Huadan Xue; Yan Zhao; Xiaofeng Zeng; Yunyun Fei; Wen Zhang
Journal:  Arthritis Res Ther       Date:  2020-01-10       Impact factor: 5.156

Review 7.  IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease.

Authors:  Annarosa Floreani; Kazuichi Okazaki; Kazushige Uchida; M Eric Gershwin
Journal:  J Transl Autoimmun       Date:  2020-12-19

8.  Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.

Authors:  Linyang Gan; Xuan Luo; Yunyun Fei; Linyi Peng; Jiaxin Zhou; Jieqiong Li; Hui Lu; Zheng Liu; Panpan Zhang; Xiaowei Liu; Wen Zhang
Journal:  BMC Ophthalmol       Date:  2021-12-27       Impact factor: 2.209

9.  Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry.

Authors:  Ji Zongfei; Zhang Lijuan; Sun Ying; Liu Dongmei; Wu Sifan; Kong Xiufang; Ma Lingying; Liu Yun; Ma Lili; Chen Huiyong; Jiang Lindi
Journal:  Ther Adv Chronic Dis       Date:  2021-06-30       Impact factor: 5.091

10.  Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.

Authors:  Marcus Wölffer; Florian Battke; Martin Schulze; Magdalena Feldhahn; Lukas Flatz; Peter Martus; Andrea Forschner
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.